Re: Efficacy and Safety of Abiraterone Acetate in an Elderly Patient Subgroup (Aged 75 and Older) with Metastatic Castration-Resistant Prostate Cancer after Docetaxel-Based Chemotherapy

Griebling Tomas L.

首页> 外文期刊>The Journal of Urology >Re: Efficacy and Safety of Abiraterone Acetate in an Elderly Patient Subgroup (Aged 75 and Older) with Metastatic Castration-Resistant Prostate Cancer after Docetaxel-Based Chemotherapy

【24h】

Re: Efficacy and Safety of Abiraterone Acetate in an Elderly Patient Subgroup (Aged 75 and Older) with Metastatic Castration-Resistant Prostate Cancer after Docetaxel-Based Chemotherapy

机译：回复：醋酸阿比特龙在多西他赛为基础的化学疗法后对转移性去势抵抗性前列腺癌的老年患者亚组（75岁及以上）的疗效和安全性

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The Journal of Urology》 |2015年第2期|共1页
作者
Griebling Tomas L.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Re: Efficacy and Safety of Abiraterone Acetate in an Elderly Patient Subgroup (Aged 75 and Older) with Metastatic Castration-Resistant Prostate Cancer after Docetaxel-Based Chemotherapy [J] . Griebling Tomas L. The Journal of Urology . 2015,第2期

机译：回复：醋酸阿比特龙在多西他赛为基础的化学疗法后对转移性去势抵抗性前列腺癌的老年患者亚组（75岁及以上）的疗效和安全性
2. Re: Efficacy and Safety of Abiraterone Acetate in an Elderly Patient Subgroup (Aged 75 and Older) with Metastatic Castration-Resistant Prostate Cancer after Docetaxel-Based Chemotherapy [J] . Griebling Tomas L. The Journal of Urology . 2015,第2期

机译：回复：醋酸阿比特龙在多西他赛为基础的化学疗法后对转移性去势抵抗性前列腺癌的老年患者亚组（75岁及以上）的疗效和安全性
3. Efficacy and safety of abiraterone acetate in an elderly patient subgroup (aged 75 and older) with metastatic castration-resistant prostate cancer after docetaxel-based chemotherapy [J] . MuldersP.F.A., MolinaA., MarbergerM., European urology . 2014,第5期

机译：醋酸阿比特龙在多西紫杉醇类化疗后对转移性去势抵抗性前列腺癌的老年患者亚组（75岁及以上）的疗效和安全性
4. Improving Efficacy of Metastatic Tumor Segmentation to Facilitate Early Prediction of Ovarian Cancer Patients' Response to Chemotherapy [C] . Gopichandh Danala, Yunzhi Wang, Theresa Thai, Biophotonics and immune responses XII . 2017

机译：提高转移性肿瘤分割的功效，以促进卵巢癌患者对化疗的反应的早期预测
5. Investigating age varying effect of access to cancer care on immediate choice of chemotherapy among elderly women with metastatic breast cancer. [D] . Wan, Shaowei. 2010

机译：调查在转移性乳腺癌的老年妇女中，癌症治疗对立即选择化疗的年龄差异影响。
6. Efficacy and Safety of Abiraterone Acetate in Elderly (≥75 Years) Chemotherapy-Naïve Patients with Metastatic Castration-Resistant Prostate Cancer [O] . Matthew R. Smith, Dana E. Rathkopf, Peter. F.A. Mulders, -1

机译：醋酸阿比特龙在年龄≥75岁的未接受化疗的转移性去势抵抗性前列腺癌患者中的疗效和安全性
7. A Phase 2 Study of Abiraterone Acetate in Japanese Men with Metastatic Castration-resistant Prostate Cancer Who Had Received Docetaxel-based Chemotherapy [O] . T. Satoh, H. Uemura, K. Tanabe, 2014

机译：含有基于多西紫杉醇的化疗的日本男性醋酸甲酸乙酸阿乙酸盐的第2期研究

Re: Efficacy and Safety of Abiraterone Acetate in an Elderly Patient Subgroup (Aged 75 and Older) with Metastatic Castration-Resistant Prostate Cancer after Docetaxel-Based Chemotherapy

著录项

相似文献

相关主题

期刊订阅